{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:52:59Z","timestamp":1793170379787,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001648","name":"European Foundation for the Study of Diabetes","doi-asserted-by":"publisher","award":["EFSD-Lilly Young Investigator Research Award 2019"],"award-info":[{"award-number":["EFSD-Lilly Young Investigator Research Award 2019"]}],"id":[{"id":"10.13039\/501100001648","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"crossref","award":["Center for Basic Metabolic Research"],"award-info":[{"award-number":["Center for Basic Metabolic Research"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","award":["2016-2394"],"award-info":[{"award-number":["2016-2394"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Det Frie Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["6110-00660"],"award-info":[{"award-number":["6110-00660"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00125-020-05288-0","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T03:10:33Z","timestamp":1602472233000},"page":"142-151","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Paracrine regulation of somatostatin secretion by insulin and glucagon in mouse pancreatic islets"],"prefix":"10.1007","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3604-000X","authenticated-orcid":false,"given":"Berit","family":"Svendsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6853-3805","authenticated-orcid":false,"given":"Jens J.","family":"Holst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,12]]},"reference":[{"issue":"7","key":"5288_CR1","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1073\/pnas.0510790103","volume":"103","author":"O Cabrera","year":"2006","unstructured":"Cabrera O, Berman DM, Kenyon NS, Ricordi C, Berggren PO, Caicedo A (2006) The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci U S A 103(7):2334\u20132339. https:\/\/doi.org\/10.1073\/pnas.0510790103","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"5288_CR2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/BF00265095","volume":"32","author":"JI Stagner","year":"1989","unstructured":"Stagner JI, Samols E, Marks V (1989) The anterograde and retrograde infusion of glucagon antibodies suggests that A cells are vascularly perfused before D cells within the rat islet. Diabetologia 32(3):203\u2013206. https:\/\/doi.org\/10.1007\/BF00265095","journal-title":"Diabetologia"},{"issue":"1","key":"5288_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2337\/diab.41.1.93","volume":"41","author":"JI Stagner","year":"1992","unstructured":"Stagner JI, Samols E (1992) The vascular order of islet cellular perfusion in the human pancreas. Diabetes 41(1):93\u201397. https:\/\/doi.org\/10.2337\/diab.41.1.93","journal-title":"Diabetes"},{"issue":"1","key":"5288_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0014-5793(77)80930-7","volume":"81","author":"V Schusdziarra","year":"1977","unstructured":"Schusdziarra V, Dobbs RE, Harris V, Unger RH (1977) Immunoreactive somatostatin levels in plasma of normal and alloxan diabetic dogs. FEBS Lett 81(1):69\u201372. https:\/\/doi.org\/10.1016\/0014-5793(77)80930-7","journal-title":"FEBS Lett"},{"issue":"Suppl 2","key":"5288_CR5","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0196-9781(81)90034-6","volume":"2","author":"JJ Holst","year":"1981","unstructured":"Holst JJ, Sottimano C, Olesen M, Lindkaer S, Nielsen OV (1981) Nervous control of gastro-pancreatic somatostatin secretion in pigs. Peptides 2(Suppl 2):215\u2013221","journal-title":"Peptides"},{"issue":"6","key":"5288_CR6","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1172\/JCI111658","volume":"74","author":"H Maruyama","year":"1984","unstructured":"Maruyama H, Hisatomi A, Orci L, Grodsky GM, Unger RH (1984) Insulin within islets is a physiologic glucagon release inhibitor. J Clin Invest 74(6):2296\u20132299. https:\/\/doi.org\/10.1172\/JCI111658","journal-title":"J Clin Invest"},{"issue":"5a","key":"5288_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/0002-9343(88)90395-6","volume":"85","author":"E Samols","year":"1988","unstructured":"Samols E, Stagner JI (1988) Intra-islet regulation. Am J Med 85(5a):31\u201335","journal-title":"Am J Med"},{"issue":"1","key":"5288_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2337\/diabetes.48.1.77","volume":"48","author":"U Kumar","year":"1999","unstructured":"Kumar U, Sasi R, Suresh S et al (1999) Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis. Diabetes 48(1):77\u201385. https:\/\/doi.org\/10.2337\/diabetes.48.1.77","journal-title":"Diabetes"},{"issue":"2","key":"5288_CR9","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/00129039-200006000-00007","volume":"8","author":"GM Portela-Gomes","year":"2000","unstructured":"Portela-Gomes GM, Stridsberg M, Grimelius L, Oberg K, Janson ET (2000) Expression of the five different somatostatin receptor subtypes in endocrine cells of the pancreas. Appl Immunohistochem Mol Morphol 8(2):126\u2013132. https:\/\/doi.org\/10.1097\/00129039-200006000-00007","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"2","key":"5288_CR10","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1210\/endo-96-2-370","volume":"96","author":"DG Johnson","year":"1975","unstructured":"Johnson DG, Ensinck JW, Koerker D, Palmer J, Goodner CJ (1975) Inhibition of glucagon and insulin secretion by somatostatin in the rat pancreas perfused in situ. Endocrinology 96(2):370\u2013374. https:\/\/doi.org\/10.1210\/endo-96-2-370","journal-title":"Endocrinology"},{"issue":"12","key":"5288_CR11","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1007\/s00125-008-1149-y","volume":"51","author":"J de Heer","year":"2008","unstructured":"de Heer J, Rasmussen C, Coy DH, Holst JJ (2008) Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas. Diabetologia 51(12):2263\u20132270. https:\/\/doi.org\/10.1007\/s00125-008-1149-y","journal-title":"Diabetologia"},{"issue":"10","key":"5288_CR12","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1007\/s00125-016-4033-1","volume":"59","author":"AE Adriaenssens","year":"2016","unstructured":"Adriaenssens AE, Svendsen B, Lam BY et al (2016) Transcriptomic profiling of pancreatic alpha, beta and delta cell populations identifies delta cells as a principal target for ghrelin in mouse islets. Diabetologia 59(10):2156\u20132165. https:\/\/doi.org\/10.1007\/s00125-016-4033-1","journal-title":"Diabetologia"},{"issue":"2","key":"5288_CR13","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2337\/db08-0792","volume":"58","author":"AC Hauge-Evans","year":"2009","unstructured":"Hauge-Evans AC, King AJ, Carmignac D et al (2009) Somatostatin secreted by islet delta-cells fulfills multiple roles as a paracrine regulator of islet function. Diabetes 58(2):403\u2013411. https:\/\/doi.org\/10.2337\/db08-0792","journal-title":"Diabetes"},{"issue":"5","key":"5288_CR14","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.celrep.2018.10.018","volume":"25","author":"B Svendsen","year":"2018","unstructured":"Svendsen B, Larsen O, Gabe MBN et al (2018) Insulin secretion depends on intra-islet glucagon signaling. Cell Rep 25(5):1127\u20131134.e1122. https:\/\/doi.org\/10.1016\/j.celrep.2018.10.018","journal-title":"Cell Rep"},{"issue":"7409","key":"5288_CR15","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/s0140-6736(65)90761-0","volume":"2","author":"E Samols","year":"1965","unstructured":"Samols E, Marri G, Marks V (1965) Promotion of insulin secretion by glucagon. Lancet 2(7409):415\u2013416. https:\/\/doi.org\/10.1016\/s0140-6736(65)90761-0","journal-title":"Lancet"},{"issue":"8","key":"5288_CR16","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1007\/s001250051484","volume":"43","author":"P Huypens","year":"2000","unstructured":"Huypens P, Ling Z, Pipeleers D, Schuit F (2000) Glucagon receptors on human islet cells contribute to glucose competence of insulin release. Diabetologia 43(8):1012\u20131019. https:\/\/doi.org\/10.1007\/s001250051484","journal-title":"Diabetologia"},{"issue":"1","key":"5288_CR17","doi-asserted-by":"publisher","first-page":"66","DOI":"10.2337\/diab.47.1.66","volume":"47","author":"K Moens","year":"1998","unstructured":"Moens K, Flamez D, Van SC, Ling Z, Pipeleers D, Schuit F (1998) Dual glucagon recognition by pancreatic beta-cells via glucagon and glucagon-like peptide 1 receptors. Diabetes 47(1):66\u201372. https:\/\/doi.org\/10.2337\/diab.47.1.66","journal-title":"Diabetes"},{"issue":"1","key":"5288_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41467-018-08193-8","volume":"10","author":"E Vergari","year":"2019","unstructured":"Vergari E, Knudsen JG, Ramracheya R et al (2019) Insulin inhibits glucagon release by SGLT2-induced stimulation of somatostatin secretion. Nat Commun 10(1):139. https:\/\/doi.org\/10.1038\/s41467-018-08193-8","journal-title":"Nat Commun"},{"issue":"12","key":"5288_CR19","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/0026-0495(80)90152-3","volume":"29","author":"RN Honey","year":"1980","unstructured":"Honey RN, Fallon MB, Weir GC (1980) Effects of exogenous insulin, glucagon, and somatostatin on islet hormone secretion in the perfused chicken pancreas. Metab Clin Exp 29(12):1242\u20131246. https:\/\/doi.org\/10.1016\/0026-0495(80)90152-3","journal-title":"Metab Clin Exp"},{"issue":"7","key":"5288_CR20","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1007\/s00125-012-2546-9","volume":"55","author":"AC Hauge-Evans","year":"2012","unstructured":"Hauge-Evans AC, Anderson RL, Persaud SJ, Jones PM (2012) Delta cell secretory responses to insulin secretagogues are not mediated indirectly by insulin. Diabetologia 55(7):1995\u20132004. https:\/\/doi.org\/10.1007\/s00125-012-2546-9","journal-title":"Diabetologia"},{"issue":"1","key":"5288_CR21","doi-asserted-by":"publisher","first-page":"E60","DOI":"10.1152\/ajpendo.00547.2011","volume":"304","author":"J Pedersen","year":"2013","unstructured":"Pedersen J, Ugleholdt RK, Jorgensen SM et al (2013) Glucose metabolism is altered after loss of L cells and alpha-cells but not influenced by loss of K cells. Am J Physiol Endocrinol Metab 304(1):E60\u2013E73. https:\/\/doi.org\/10.1152\/ajpendo.00547.2011","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"5288_CR22","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1073\/pnas.0237106100","volume":"100","author":"RW Gelling","year":"2003","unstructured":"Gelling RW, Du XQ, Dichmann DS et al (2003) Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice. Proc Natl Acad Sci U S A 100(3):1438\u20131443","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"5288_CR23","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.bbrc.2008.08.151","volume":"376","author":"L Schaffer","year":"2008","unstructured":"Schaffer L, Brand CL, Hansen BF et al (2008) A novel high-affinity peptide antagonist to the insulin receptor. Biochem Biophys Res Commun 376(2):380\u2013383. https:\/\/doi.org\/10.1016\/j.bbrc.2008.08.151","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"5288_CR24","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1172\/jci115012","volume":"87","author":"C Orskov","year":"1991","unstructured":"Orskov C, Jeppesen J, Madsbad S, Holst JJ (1991) Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine. J Clin Invest 87(2):415\u2013423. https:\/\/doi.org\/10.1172\/jci115012","journal-title":"J Clin Invest"},{"issue":"3","key":"5288_CR25","doi-asserted-by":"publisher","first-page":"E469","DOI":"10.1152\/ajpendo.1995.269.3.E469","volume":"269","author":"CL Brand","year":"1995","unstructured":"Brand CL, Jorgensen PN, Knigge U et al (1995) Role of glucagon in maintenance of euglycemia in fed and fasted rats. Am J Physiol Endocrinol Metab 269(3):E469\u2013E477. https:\/\/doi.org\/10.1152\/ajpendo.1995.269.3.E469","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"11","key":"5288_CR26","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1021\/jm9806289","volume":"42","author":"SJ Hocart","year":"1999","unstructured":"Hocart SJ, Jain R, Murphy WA, Taylor JE, Coy DH (1999) Highly potent cyclic disulfide antagonists of somatostatin. J Med Chem 42(11):1863\u20131871. https:\/\/doi.org\/10.1021\/jm9806289","journal-title":"J Med Chem"},{"issue":"8","key":"5288_CR27","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1021\/jm0005048","volume":"44","author":"WG Rajeswaran","year":"2001","unstructured":"Rajeswaran WG, Hocart SJ, Murphy WA, Taylor JE, Coy DH (2001) Highly potent and subtype selective ligands derived by N-methyl scan of a somatostatin antagonist. J Med Chem 44(8):1305\u20131311. https:\/\/doi.org\/10.1021\/jm0005048","journal-title":"J Med Chem"},{"issue":"1","key":"5288_CR28","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1124\/jpet.107.120006","volume":"322","author":"R Jorgensen","year":"2007","unstructured":"Jorgensen R, Kubale V, Vrecl M, Schwartz TW, Elling CE (2007) Oxyntomodulin differentially affects glucagon-like peptide-1 receptor beta-arrestin recruitment and signaling through Galpha(s). J Pharmacol Exp Ther 322(1):148\u2013154. https:\/\/doi.org\/10.1124\/jpet.107.120006","journal-title":"J Pharmacol Exp Ther"},{"issue":"11","key":"5288_CR29","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.2337\/db17-0880","volume":"67","author":"BK Lai","year":"2018","unstructured":"Lai BK, Chae H, Gomez-Ruiz A et al (2018) Somatostatin is only partly required for the glucagonostatic effect of glucose but is necessary for the glucagonostatic effect of KATP channel blockers. Diabetes 67(11):2239\u20132253. https:\/\/doi.org\/10.2337\/db17-0880","journal-title":"Diabetes"},{"issue":"7","key":"5288_CR30","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1007\/s00125-019-4857-6","volume":"62","author":"Q Yu","year":"2019","unstructured":"Yu Q, Shuai H, Ahooghalandari P, Gylfe E, Tengholm A (2019) Glucose controls glucagon secretion by directly modulating cAMP in alpha cells. Diabetologia 62(7):1212\u20131224. https:\/\/doi.org\/10.1007\/s00125-019-4857-6","journal-title":"Diabetologia"},{"issue":"3","key":"5288_CR31","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/BF00252662","volume":"21","author":"J Dolais-Kitabgi","year":"1981","unstructured":"Dolais-Kitabgi J, Kitabgi P, Freychet P (1981) Glucose and glucagon do stimulate somatostatin release from isolated pancreatic islets. Diabetologia 21(3):238. https:\/\/doi.org\/10.1007\/BF00252662","journal-title":"Diabetologia"},{"issue":"7","key":"5288_CR32","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.molmet.2016.04.007","volume":"5","author":"MR DiGruccio","year":"2016","unstructured":"DiGruccio MR, Mawla AM, Donaldson CJ et al (2016) Comprehensive alpha, beta and delta cell transcriptomes reveal that ghrelin selectively activates delta cells and promotes somatostatin release from pancreatic islets. Mol Metab 5(7):449\u2013458. https:\/\/doi.org\/10.1016\/j.molmet.2016.04.007","journal-title":"Mol Metab"},{"issue":"5","key":"5288_CR33","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1507\/endocrj1954.29.503","volume":"29","author":"K Murakami","year":"1982","unstructured":"Murakami K, Taniguchi H, Tamagawa M, Ejiri K, Baba S (1982) Modulation of somatostatin release by endogenous glucagon and insulin: physiological relationship between A, B and D cells in rat pancreatic islets. Endocrinol Jpn 29(5):503\u2013508. https:\/\/doi.org\/10.1507\/endocrj1954.29.503","journal-title":"Endocrinol Jpn"},{"key":"5288_CR34","doi-asserted-by":"publisher","unstructured":"Capozzi ME, Svendsen B, Encisco SE et al (2019) \u03b2 Cell tone is defined by proglucagon peptides through cAMP signaling. JCI Insight 4(5). https:\/\/doi.org\/10.1172\/jci.insight.126742","DOI":"10.1172\/jci.insight.126742"},{"issue":"11 Suppl 1","key":"5288_CR35","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/s0026-0495(76)80177-1","volume":"25","author":"GS Patton","year":"1976","unstructured":"Patton GS, Dobbs R, Orci L, Vale W, Unger RH (1976) Stimulation of pancreatic immunoreactive somatostatin (IRS) release by glucagon [proceedings]. Metab Clin Exp 25(11 Suppl 1):1499. https:\/\/doi.org\/10.1016\/s0026-0495(76)80177-1","journal-title":"Metab Clin Exp"},{"issue":"37","key":"5288_CR36","doi-asserted-by":"publisher","first-page":"16009","DOI":"10.1073\/pnas.1006639107","volume":"107","author":"RH Unger","year":"2010","unstructured":"Unger RH, Orci L (2010) Paracrinology of islets and the paracrinopathy of diabetes. Proc Natl Acad Sci 107(37):16009\u201316012. https:\/\/doi.org\/10.1073\/pnas.1006639107","journal-title":"Proc Natl Acad Sci"},{"issue":"s1","key":"5288_CR37","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1463-1326.2011.01449.x","volume":"13","author":"D D\u2019Alessio","year":"2011","unstructured":"D\u2019Alessio D (2011) The role of dysregulated glucagon secretion in type 2 diabetes. Diabetes Obes Metab 13(s1):126\u2013132. https:\/\/doi.org\/10.1111\/j.1463-1326.2011.01449.x","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"5288_CR38","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2337\/db11-0690","volume":"61","author":"JT Yue","year":"2012","unstructured":"Yue JT, Burdett E, Coy DH, Giacca A, Efendic S, Vranic M (2012) Somatostatin receptor type 2 antagonism improves glucagon and corticosterone counterregulatory responses to hypoglycemia in streptozotocin-induced diabetic rats. Diabetes 61(1):197\u2013207. https:\/\/doi.org\/10.2337\/db11-0690","journal-title":"Diabetes"},{"issue":"7","key":"5288_CR39","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.2337\/db12-1523","volume":"62","author":"JT Yue","year":"2013","unstructured":"Yue JT, Riddell MC, Burdett E, Coy DH, Efendic S, Vranic M (2013) Amelioration of hypoglycemia via somatostatin receptor type 2 antagonism in recurrently hypoglycemic diabetic rats. Diabetes 62(7):2215\u20132222. https:\/\/doi.org\/10.2337\/db12-1523","journal-title":"Diabetes"},{"issue":"8","key":"5288_CR40","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.2337\/db13-0164","volume":"62","author":"N Karimian","year":"2013","unstructured":"Karimian N, Qin T, Liang T et al (2013) Somatostatin receptor type 2 antagonism improves glucagon counterregulation in biobreeding diabetic rats. Diabetes 62(8):2968\u20132977. https:\/\/doi.org\/10.2337\/db13-0164","journal-title":"Diabetes"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-020-05288-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-020-05288-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-020-05288-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T15:50:55Z","timestamp":1634053855000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-020-05288-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,12]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["5288"],"URL":"https:\/\/doi.org\/10.1007\/s00125-020-05288-0","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,12]]},"assertion":[{"value":"7 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}